The Effect of an Individual Empowerment Program Provided to Relatives of Schizophrenia Patients
NCT ID: NCT07173192
Last Updated: 2025-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
66 participants
INTERVENTIONAL
2025-05-15
2026-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Personal Recovery Based Psychoeducation For Schizophrenia
NCT06284096
ACT-Based Psychoeducation for Schizophrenia Caregivers
NCT06971328
Salutogenic Approach Based Interview With People With Schizophrenia
NCT04740944
The Effectiveness of Psychosocial Skills Training Applied to Individuals Diagnosed With Schizophrenia
NCT07017881
Application of Group Interpersonal Psychotherapy (IPT-G) to Family Members Caring for Patients With Schizophrenia
NCT05870384
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
These findings reveal that caregivers are at risk for mental illness and require special support from other family members, the community, and healthcare providers. Zimmerman (1981) defined self-efficacy as "an individual's judgments about their ability to accomplish and succeed in a task." Self-efficacy is an individual's beliefs and judgments about their capacity to overcome difficult situations they may encounter in the future (Fitzgeraldson et al., 2024; Durmaz, 2011). Another definition describes it as the belief in oneself during the process of achieving a desired outcome (Ebrahem et al., 2024). An increase in an individual's perception of self-efficacy leads to the display of positive health behaviors.Low self-efficacy feelings can lead to low self-esteem and pessimism in individuals, while high self-efficacy feelings encourage overcoming difficulties and working towards goals (Durmaz et al., 2014).
The caregiver's internal motivation is one of the determining factors affecting the burden of care.
Being able to manage the symptoms of schizophrenia during the care process and cope with difficulties is of great importance for both patients and caregivers.
Ebrahem et al. (2024) examined the relationship between self-efficacy, care burden, and hope among caregivers of individuals with psychotic disorders. In a study by Ebrahem et al. (2024) examining the relationship between self-efficacy, care burden, and hope among caregivers of individuals with psychotic disorders, the self-efficacy levels of individuals caring for chronic psychotic illnesses were found to be low to moderate.
Reviewing the literature, other studies have found a negative correlation between care burden and self-efficacy.
That is, as care burden increases, caregivers' self-efficacy levels are found to be low (Ebrahem et al., 2024; Ramzani et al., 2019; Durmaz et al., 2014; Durmaz, 2011).Thongthammarat et al. (2022) examined the effectiveness of an enhanced psychological well-being intervention on the psychological well-being and care burden of family members caring for individuals with schizophrenia. Their study found that an enhanced psychological well-being intervention provided to relatives of individuals diagnosed with schizophrenia increased the psychological well-being levels of these relatives and also reduced their care burden.
Ebrahem et al. (2024) examined the relationship between self-efficacy, care burden, and hope among caregivers of individuals with psychotic disorders. Their study found that as the care burden increased among caregivers of individuals with psychotic disorders, their levels of self-efficacy decreased.The individual empowerment program includes a series of activities and strategies aimed at helping individuals discover their potential, develop their talents, and improve their quality of life. These types of programs are designed to empower individuals psychologically, socially, and economically. In particular, individual empowerment increases individuals' ability to make their own decisions, strengthens their self-confidence, and develops their ability to cope with difficulties in their lives (Krenz et al., 2013; Setyoadi et al., 2023). These programs aim to reduce the stress and difficulties experienced by patients' relatives, improve their psychosocial health, and increase their overall quality of life. (Ercan et al., 2019; Harmancı, 2016). In this context, the educational and counseling roles of psychiatric nurses toward families are critically important in reducing the burden on caregivers and developing coping mechanisms (Kaya, 2018; Gök et al., 2023). Individual empowerment programs implemented by psychiatric nurses are an important support mechanism for relatives of schizophrenia patients. These programs improve the knowledge and skills of relatives, develop their ability to cope with stress, and improve their overall quality of life (Dost, 2023; Buldukoğlu et al., 2011).It is recommended that psychiatric nurses provide education and counseling that includes coping strategies to help caregivers of individuals with psychotic disorders improve their self-efficacy (Ebrahem et al., 2024). Additionally, it has been noted that more interventional research is needed, including specialized interventions that incorporate skill development and psychoeducation for the care of schizophrenia patients, to alleviate the care burden on family members caring for schizophrenia patients (Thongthammarat et al., 2022). Psychoeducation provided to family members caring for individuals with schizophrenia has been found to have positive effects on caregivers' psychological well-being and the effective management of individuals with schizophrenia; however, more experimental studies on this topic and support for caregivers' psychological well-being are recommended (Sharma et al., 2021; Ehsan et al., 2018). Furthermore, since the studies in the literature were group studies, Kim et al. (2023) recommended that future interventions be applied individually in their meta-analysis examining the effectiveness of interventions for relatives of schizophrenia patients.No interventional studies have been found examining the effects of an individual empowerment program for patients diagnosed with schizophrenia that includes both psychoeducation and coping skills training for primary caregivers on the burden of care, psychological well-being, and self-efficacy. Considering the gaps in the literature, the aim of this study is to evaluate the effect of an individual empowerment program applied to primary caregivers of patients diagnosed with schizophrenia on the burden of care, psychological well-being, and self-efficacy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
experimental group
Data collection tools will be administered as a pre-test to individuals in the experimental and control groups. Individuals in the experimental group will receive individual empowerment training sessions as part of a six-session individual empowerment program.
Individual empowerment program
Data collection tools will be applied to individuals in the experimental and control groups as a pre-test.
Individual empowerment training sessions will be applied to individuals in the experimental group totaling (6 sessions) as part of the individual empowerment program. No intervention will be performed on individuals in the control group; they will receive standard discharge education. Data collection tools will be applied to individuals in both groups for post-tests immediately after the experimental group completes all individual empowerment program sessions.
control group
No intervention will be performed on individuals in the control group; these individuals will receive standard discharge education.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Individual empowerment program
Data collection tools will be applied to individuals in the experimental and control groups as a pre-test.
Individual empowerment training sessions will be applied to individuals in the experimental group totaling (6 sessions) as part of the individual empowerment program. No intervention will be performed on individuals in the control group; they will receive standard discharge education. Data collection tools will be applied to individuals in both groups for post-tests immediately after the experimental group completes all individual empowerment program sessions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Arel University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zeynep Dag
Servis Hemşiresi
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
zeynep dağ psychiatric nurse
Role: PRINCIPAL_INVESTIGATOR
Istanbul Arel University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Arel University
Istanbul, Cevizlibağ, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ARELU-SBF-ZD-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.